Chinese vaccine manufacturer Sinovac applied to Hong Kong health authorities in mid-October to allow children as young as three to receive its Covid-19 jabs, the government has said.

It added that the information submitted by Sinovac would be passed to the panel, which would make a recommendation to the health secretary for approval.

Currently, only people aged 18 or above can take Sinovac's CoronaVac, while those aged 12 or above can take BioNTech's Comirnaty.

It was also understood that experts were also waiting for data about inoculating children aged five to 11 with shots made by Germany’s BioNTech, the other vaccine approved for use in Hong Kong, before making any recommendations about whether children younger than 12 should receive it.

China started giving Covid-19 vaccines to children as young as three in late October, as the country grapples with the return of the Delta variant and more virus outbreaks.

Multiple places across China are rolling out vaccines to children aged between three and 11, according to reports in local media.

The shots have already been administered to those aged 12 and above, with the country green-lighting their use in those aged over three in June.